FGFR Inhibition, Pharmacokinetics, Biomarkers

Clinical trial pipeline · Data from ClinicalTrials.gov

See which FGFR Inhibition, Pharmacokinetics, Biomarkers trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1/2

NCT01202591

Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients

The purpose of this study is to assess the safety and effectiveness of AZD4547 in combination with fulvestrant vs. fulvestrant alone in ER+ breast cancer patien…

Belgium, Czechia, France127 participantsStarted 2010-12

Treatment: AZD4547, Exemestane